Biogen Sees Interest In Potential Biosimilars Deal

Biosimilars Turnover Steady In Q2; Also Provides Update On Tysabri And Tecfidera Rivals

 
• By David Wallace
  
Man in suit with glowing icons of businessmen in his hand
Biogen is “engaged with multiple interested parties” over a potential biosimilars sale • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products